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Despite being scarce in the human genome, active L1 retrotrans-
posons continue to play a significant role in its evolution. Because
of their recent expansion, many L1s are not fixed in humans, and,
when present, their mobilization potential can vary among indi-
viduals. Previously, we showed that the great majority of retro-
transposition events in humans are caused by highly active, or hot,
L1s. Here, in four populations of diverse geographic origins (160
haploid genomes), we investigated the degree of sequence poly-
morphism of three hot L1s and the extent of individual variation in
mobilization capability of their allelic variants. For each locus, we
found one previously uncharacterized allele in every three to five
genomes, including some with nonsense and insertiondeletion
mutations. Single or multiple nucleotide substitutions drastically
affected the retrotransposition efficiency of some alleles. One-
third of elements were no longer hot, and these so-called cool
alleles substantially increased the range of individual susceptibility
to retrotransposition events. Adding the activity of the three
elements in each individual resulted in a surprising degree of
variation in mobilization capability, ranging from 0% to 390% of
a reference L1. These data suggest that individual variation in
retrotransposition potential makes an important contribution to
human genetic diversity.
human variation  population genetics  retrotransposon
Several types of DNA polymorphisms contribute to humangenetic diversity. Among them are SNPs, microsatellite poly-
morphisms, variable number tandem repeats, copy number varia-
tion of large deletions and duplications, and presenceabsence of
young retrotransposons (1–3). Here, we describe another type of
polymorphism, variation in retrotransposition capability, due to
SNPs within hot L1s.
L1 retrotransposons have populated eukaryote genomes for
150 million years and account for 17% of the human genome
(1). L1s are scattered throughout the genome and include 5-
truncated, rearranged, and mutated elements along with intact,
full-length (FL) 6-kb copies (1, 4). Presently, L1s are the only
autonomous mobile elements in the human genome (4). Whether
active or inactive, L1-derived sequences contribute to genome
variability by promoting ectopic recombination or by altering the
regulatory properties and expression patterns of genes (5–8).
However, only the youngest, active L1s can generate genomic
variability through insertional mutagenesis (8–11), deletion (12–
14), exon-shuffling (15), or transmobilization of processed pseu-
dogenes (16) and nonautonomous sequences, like SVAs and Alus
(17–19). Importantly, only mobile L1s can ensure their own survival
in the human genome.
Mobile L1s are bicistronic entities flanked by a 5 UTR carrying
internal sense (20) and antisense (5) promoters and a 3 UTR with
a weak polyA signal. The 5 cistron ORF1 encodes a 40-kDa
RNA-binding protein (21) with chaperone activity (22). The 3
cistron ORF2 encodes a 150-kDa protein with conserved endonu-
clease (23), reverse transcriptase (24), and zinc knuckle (25)
domains. Both proteins are required for retrotransposition (23, 26),
which occurs through a FL, polyadenylated RNA intermediate by
target-primed reverse transcription that generates target site du-
plications flanking the retrotransposed copy (27, 28).
In order for an active L1 to affect an individual genome or a
population, the L1 must first be present in the genome. This obvious
requirement is not necessarily fulfilled by active L1s, because they
belong to the youngest subfamily (L1-Ta). Indeed, their recent
mobilization is reflected by presenceabsence polymorphism in
individuals and populations (29, 30), which represents a significant
source of diversity in the contemporary human genome (2, 29–33).
From activity analyses of L1 elements with functional ORFs in the
human genome working draft (HGWD), we estimated that the
average individual contains 80–100 potentially mobile L1s, and 6
L1s per haploid genome (12 per individual) are highly active or hot
(34). Significantly, hot L1s account for the bulk of L1s known to
retrotranspose in present-day humans (34).
The aggregate of active L1s carried by an individual determines
hisher overall retrotransposition capability. A second individual,
however, is likely to have a different set of active L1s and a different
retrotransposition capability. Indeed, in addition to presence
absence polymorphism, large differences in retrotransposition ac-
tivity of two alleles of LRE1, the first active human L1 isolated,
demonstrated the potential contribution of alleles of active L1s to
individual variability (35–37).
Based on these preliminary data, we analyzed sequence
polymorphisms in three testable hot L1s (34) and the individual
variation produced by the mobilization capacity of allelic vari-
ants. Each hot L1 was analyzed in 161–206 haploid genomes from
different geographic origins. We found one previously unchar-
acterized allele in every three to five L1s sequenced and three to
four wide-ranging activity levels per locus. Many alleles had
activity levels 25% of a reference L1, and we call them cool.
When the allelic activity potential at all three loci was combined,
hot and cool L1s, along with presenceabsence polymorphism,
suggested that there is substantial individual variation in retro-
transposition capability.
Results
PresenceAbsence Polymorphism. Three of six hot L1s described in
ref. 34 were excluded from our study because two are very rare
(Al356438 and Ac004200), and one is inserted within older L1
sequences (Al137845). We determined presenceabsence frequen-
cies for the remaining three hot elements in 161–206 haploid
genomes of different geographic origins (Table 1). The frequency
of each L1 varied from population to population (Table 1), but none
of the elements departed significantly from Hardy–Weinberg equi-
librium in any population. Overall insertion frequencies of L1A
(Al512428), L1B (Ac02980), and L1C (Ac021017) were consistent
with previous analyses (2, 29–31, 34), indicating that the Ta-1
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subfamily is expanding in humans, and most of its members are
polymorphic (29).
Sequence Polymorphism. We obtained complete sequence data for
35 of 40 genomes with L1A, 59 of 67 genomes with L1B, and 78 of
96 genomes with L1C (Fig. 1 A, B, and C). We found a previously
uncharacterized allele in every 5 genomes for L1A and in every 3
genomes for L1B and L1C. L1A had 17 polymorphic sites among
8 alleles, whereas L1B and L1C had 19 and 26 polymorphic sites
among 18 and 26 alleles, respectively. Unexpected changes included
a 1-nt insertion in an allele of L1C, a 3-nt deletion shared by three
alleles of L1B, and a total of four different nonsense mutations, two
in a relatively common allele of L1A and two in separate alleles of
L1C. Finding nonsense-containing alleles of active L1s led us to
analyze nonsense-containing L1s in HGWD for active alleles, see
Supporting Discussion in Supporting Text, which is published as
supporting information on the PNAS web site. Nucleotide diversity
levels fell within ranges described for humans across coding and
noncoding regions (Table 2) (38–40).
We used three tests to assess whether the three L1s were evolving
neutrally (Table 2). No test for L1A was significant. For L1C, all
three tests, as well as the Fu’s FS test for L1B, generated significant
negative values. These results were more significant (P  0.01) for
both elements in the case of Fu’s FS, a test known to be sensitive to
an excess of low-frequency alleles (41). Indeed, L1B and L1C have
a high proportion of singleton alleles, 20% (12 of 59) and 27% (21
of 78), respectively (Fig. 1). Formally, these results indicate that L1B
and L1C depart from neutral evolution, as discussed below.
Network Phylogenies of L1A, L1B, and L1C. We reconstructed phy-
logenies of the three L1s by using Median Joining (MJ) networks
(42, 43) (Fig. 5 A, C, and D). Because the ancestral allele is usually
the most frequent (38), and MJ networks integrate both allele
frequencies (area of the nodes, Fig. 5 and Table 3, which are
published as supporting information on the PNAS web site) and
evolutionary relationships (network position), the ancestral allele
can usually be inferred by its size and position within the network.
For both L1B and L1C, the most likely ancestral allele was easily
inferred as allele 1, because it was central in the network and had
the highest allele frequency. For L1A, allele 1, the most central
allele (Fig. 5A), was not the most frequent, whereas allele 2,
although not central, had the highest frequency in the sample. The
consensus sequence for the element is ambiguous at nucleotide
2,104, where either C (Ser-39, allele 1) or G (Cys-39) is possible.
Consensus Cys-39 was not among the alleles, either because it was
not sampled or because it became extinct (43). When reconstructed
as sequence , Cys-39 was central in the network (Fig. 5B).
Moreover, Cys-39 is found in 54% of L1 clade non-LTR retro-
transposons, whereas Ser-39 is found in only 9% (44). To test the
retrotransposition activity of consensus Cys-39, we recreated it in a
chimeric element, which had high activity (see Supporting Methods
and Supporting Results in Supporting Text), whereas Ser-39 (allele 1)
had low activity (Fig. 1). Thus, although consensus Cys-39 is less
parsimonious, its network features, evolutionary conservation, and
activity level all suggest that it is the most likely ancestor of L1A.
Allelic Variation in Retrotransposition Capability: Hot and Cool Alleles.
We tested the mobilization capability of 46 of 52 (88%) alleles of
L1A, L1B, and L1C in a retrotransposition assay in human 143B
cells (34, 45). Supported by a statistical algorithm, we clustered the
alleles into percent activity categories ([x]) according to their mean
activity and variance (Fig. 1 A, B, and C; and see Materials and
Methods and Supporting Methods in Supporting Text). The activity
categories of L1A were [0], [15], and [120]; activity categories of
L1B were [20], [85], and [175]; and activity categories of L1C were
[0], [5], [10], and [25] (Fig. 1 A, B, and C). The presumed ancestor
of L1B and L1C, as determined by the network phylogenies, along
with the hypothetical ancestor of L1A, reconstructed sequence 
(Supporting Text), were in the highest activity categories. We found
nucleotide changes that significantly altered the retrotransposition
activity (see Discussion). For each element, an analysis of the






L1A (A1512428) n  48 n  50 n  50 n  40 n  8 n  10 n  206
Freq. present 0.35 0.12 0.16 0.1 0 0.5 0.19 0.31
L1B (Ac02980) n  33 n  41 n  36 n  31 n  12 n  8 n  161
Freq. present 0.67 0.12 0.42 0.68 0.33 0.63 0.46 0.5
L1C (Ac021017) n  48 n  50 n  50 n  40 n  8 n  8 n  206
Freq. present 0.1 0.86 0.44 0.45 0.3 0.63 0.46 0.5
n, number of genomes analyzed; Het*, unbiased heterozygosity; Pak, Pakistani; Freq., frequency.
Table 2. Population summary statistics, neutrality tests, and coalescence calculations
Locus name L1A (A1512428) L1B (Ac02980) L1C (Ac021017)
Sample size 35 59 78
Number of alleles 8 18 26
Number of polymorphic sites 17 18† 25‡
Nucleotide diversity () (103) 0.81 0.35 0.21
Tajima’s D 0.59 (NS) 1.38 (NS) 2.39 (P  0.01)
Fu and Li’s D* 1.22 (NS) 2.13 (NS) 5.18 (P  0.05)
Fu’s Fs 2.31 (NS) 9.72 (P  0.01) 28.65 (P  0.01)
Coalescence time (103 years) 590  160 230  70 120  35
D and D* were calculated with DNASP and Fs with ARLEQUIN (1,000 simulations). Coalescence time, assuming a
nucleotide substitution rate 2.3  108 per site per generation and a generation time of 25 years. NS, not
significant.
†In addition, one codon is deleted in alleles 2, 3, and 18.
‡In addition, allele 11 has a G insertion.




































changes and their effect on L1 structure is presented in Supporting
Results in Supporting Text.
For the three elements, 22 of 46 tested alleles had 25% or greater
activity compared with the reference L1 (L1RP) and were hot (34).
The remaining 24 alleles (5 of 8 L1A, 3 of 16 L1B, and 16 of 22 L1C)
had activity 25% of L1RP and were cool. Of all elements at loci
containing hot L1s, 33% (57 of 170) were cool (Fig. 1).
L1 Retrotransposition Potential in Individuals and Populations. The
number of possible genotypes in an individual for a locus with n
alleles is n(n 	 1)2 or 36 for L1A, 171 for L1B, and 351 for L1C,
with 8, 18, and 26 alleles, respectively. Because three or four activity
categories were identified per locus, the many possible genotypes
reduce to only 6, 10, and 9 possible phenotypes, respectively (Table
4, which is published as supporting information on the PNAS web
site). Of those possible phenotypes, 66%, 80%, and 44% per locus
correspond to hot L1 phenotypes, defined as having a biallelic
activity 25% that of L1RP (Table 4). The remaining phenotypes
with biallelic activity 25% of L1RP were defined as cool L1
phenotypes. After assigning the activity value to the allelic variants
Fig. 1. Alleles and activity variants of L1A, L1B, and L1C. (A–C Top) Nucleotide changes relative to HGWD sequence (allele 1). Amino acid changes are in
parentheses. The retrotransposition activity (%L1RP) of each allele is shown at left. (A–C Bottom) A scaled L1 sequence. Lines indicate the location of each change.
ORF1 and ORF2 (gray boxes) appear separated by the inter ORF (white box). Hatched boxes represent (left to right) leucine zipper, endonuclease, reverse
transcriptase, and zinc knuckle. Black boxes in ORF2 represent sites A and B, putative ORF1p-binding sites to L1 RNA (57). (A) L1A. 17 polymorphic sites distributed
in 8 alleles (35 genomes). A circle denotes the change responsible for an 87% reduction in activity. (B) L1B. Nineteen polymorphic sites distributed in 18 alleles
(59 genomes). Circles indicate potential changes that reduce activity by 50–88%. (C) L1C. Twenty-six polymorphic sites distributed in 26 alleles (72 genomes).
Circles denote changes potentially responsible for an 80% reduction in activity. For alleles marked with an asterisk or denoted nd, the activity was not tested
because the alleles could not be cloned. *, the activity value was predicted from sequence similarities to closely related, tested alleles; nd, the activity value could
not be predicted because the amino acid changes were not present in other alleles.









































that each individual carried at L1A, L1B, and L1C loci, we observed
that only 11% (9 of 80), 44% (35 of 79), and 45% (36 of 80) of
phenotypes per locus were hot (Table 4).
For each individual, we added the activity values per locus to
obtain the total L1 activity potential (3 L1s combined; see Table 5,
which is published as supporting information on the PNAS web
site). Fig. 2 shows the wide distribution of L1 activity potentials per
individual in every population (from 0% to 300%). Of the 80
individuals, one was excluded because his L1B element could not
be isolated (Table 5). Among the remaining 79 individuals, 18% did
not have a total hot L1 phenotype, 56% had a hot phenotype
between 25% and 200%, and 26% had a very hot phenotype
200% (Fig. 2). This latter group is likely at higher risk than the
others of undergoing a retrotransposition event.
To obtain an overall L1 activity potential per population, we
added the value from all individuals in a population and divided by
the number of individuals (Table 5 and Fig. 3). We tested whether
the different populations were statistically different in their overall
L1 activity potential. There was a 2-fold difference between the
relative activity potential of the highest (South Americans, 180%)
and the lowest group (Asians, 81%). The hypothesis that all
population means are equal was marginally rejected by an ANOVA
test (P  0.036) with South American and African means differing
from those of Asians and Europeans. Note that the variation in L1
activity potential among individuals within populations is much
larger (0–390%) than that among individuals between different
populations (81–180%), a result consistent with other human
population studies (46).
Discussion
Thanks to our natural mutagenesis system combining genotype
with functional assays, our data contribute to the complex struc-
turefunction map of human L1s (36, 47–49), identifying essential,
preferred, and dispensable amino acids. In ORF2p, C39, A604, and
F725 are essential because their nonconservative, nonsynonymous
substitutions produced 85–95% reductions in retrotransposition
activity. C39 is at the center of endonuclease subdomain II, four
amino acids upstream of D43, a characterized active-site residue of
exonuclease III activity (50). A604 is in reverse transcriptase (RT)
subdomain III and, along with F605, is conserved in all non-LTR
retrotransposons of various species (51). F725 in RT subdomain VI
(9) is slightly less conserved than F605 but also appears to be
essential for retrotransposition. Substitutions in preferred amino
acids resulted in 30–50% reductions in activity. These reductions
were found within ORF1 (R24 and R49) and ORF2 (S723, Q925,
and Y1054). Finally, dispensable amino acids, substitution of which
does not affect L1 mobility, were found in ORF1 (S12) and in
ORF2 (S245, A290, V459, A951, and C1020). Consistent with
phylogenetic analyses, these amino acids are located outside con-
served domains (44, 50). Of 8 L1A, 16 L1B, and 22 L1C alleles
tested, 62%, 18%, and 22%, respectively, had dramatic reductions
(80–100%) in retrotransposition activity, not surprising, given that
ORF2p is a multifunctional modular protein and that an intact
ORF1p is also required for retrotransposition (26).
A major conclusion of this work, that hot and cool alleles of highly
active L1s produce extensive variation in individual retrotranspo-
sition capability, rests on the proposition that L1 activity in cell
culture mirrors L1 activity in vivo. But L1 expression in vivo depends
on a number of factors not evaluated in the cell culture assay,
including chromatin status, presence of appropriate transcription
factors in the appropriate cell type, and DNA methylation, among
others (see ref. 11 for review). As a first approximation, we asked
whether the genomic region into which the element is inserted
allows its expression. L1A is located within intron 21 of gene
C6orf32–001 on chromosome 6 (see Supporting Discussion in Sup-
Fig. 2. Combined retrotransposition potential of three hot L1s per individual in four populations. From 26% (African) to 55% (South American) of individuals
per population have a unique L1 activity potential. White, black, and hatched bars represent individuals lacking a hot L1 phenotype (25%), having an
intermediate L1 activity, and having a high L1 activity (200%), respectively. *, The African distribution is based on 19 individuals (Table 5).
Fig. 3. Average retrotransposition potential of three hot L1s in four popu-
lations. The total retrotransposition potential of L1A, L1B, and L1C for each
individual was divided by the number of individuals in the population to
determine the average retrotransposition potential in each population. The
means of the four populations are not equal by ANOVA (P  0.036).




































porting Text for possible effects of L1A on expression of this gene).
According to the University of California Santa Cruz genome
browser, this gene is highly expressed in blood cells, indicating a
transcriptionally active environment for the expression of L1A.
L1B and L1C do not reside within or close to known or predicted
genes, and their immediate surrounding chromatin status is un-
known, although they are in regions of low guanosine plus cytosine
(GC) content (39.2%) (52). For L1B, our presenceabsence PCRs
in three male genomes analyzed suggest that it may have retro-
transposed, carrying a 3 transduction. These preliminary data,
combined with our activity data indicating that L1B is the most
active natural L1 described to date, suggest that L1B may be a
‘‘master self-propagating’’ element actively expanding in present-
day human genomes.
Although our studies suggest that L1A and L1B are expressed in
vivo, proof of that assertion is lacking. However, four of four hot L1s
analyzed to date, three in this study and the disease-causing hot L1
(LRE1) (36, 37), had common alleles that demonstrated highly
variable retrotransposition activity in cell culture. These data
suggest that the great bulk of hot L1s responsible for most in vivo
retrotransposition have both hot and cool alleles.
Allelism data allowed us to address whether the three Ta-1
subfamily members are evolving neutrally. Because of an excess of
rare alleles, L1B and L1C showed departure from neutrality that
can be explained by either natural selection or demographic pro-
cesses (38, 39, 41). The excess of singletons could be due to recent
positive or negative selection on neighboring loci to which L1B and
L1C are linked (selective hitchhiking) (39). On the other hand,
because human populations have been subject to extreme demo-
graphic expansion in the last 50,000–100,000 years (38, 39, 41), a
conservative explanation for the excess of singleton alleles of L1B
and L1C is the drastic changes in human population size since their
insertion.
Assuming a neutral substitution rate of 2.3  108 per site per
generation and an average human generation time of 25 years (53),
we estimate the time to the most recent common ancestor as
590,000 years for L1A, 230,000 years for L1B, and 120,000
years for L1C (Table 2). These estimates are consistent with the
estimated age of the L1 subfamilies to which the elements belong.
L1A is a Ta-1nd member, an older subfamily than Ta-1d, to which
L1B and L1C belong (34, 29).
From this large-scale study of alleles of young L1s currently
expanding in the human genome, we suggest a model for how L1
insertions evolve in a population (Fig. 4). The present work and the
fact that nearly all present-day, disease-causing L1 insertions are hot
(34, 54) suggest that new insertions in a population are derived from
hot L1s. Later, as a new insertion increases in gene frequency
through genetic drift, it also acquires random mutations, some of
which reduce its retrotransposition potential from hot to cool, this
being the status of the three elements studied here. As the L1’s gene
frequency increases toward fixation, alleles continue to accumulate
mutations that render them either cool or dead for subsequent
retrotransposition.
Combining the retrotransposition potential of the three hot L1s
studied, we found that 18% (14 of 79) of individuals lacked a hot
phenotype (25%, Fig. 2), whereas another 26% (21 of 79) have
a very high retrotransposition capability (200%, Fig. 2). Thus,
nearly half of individuals fall at the extremes of the distribution of
retrotransposition capability of these elements, suggesting that
individuals vary significantly in their risk of a new insertion during
meiosis or during development of their offspring.
But would this degree of individual variation still stand if other
hot L1s in the population were included in the analysis? In other
words, do L1A, L1B, and L1C combined constitute a significant
fraction of the hot L1 activity in world populations? In HGWD,
L1A, L1B, and L1C were among six elements with gene frequencies
0.47 that were hot (L1A, L1B, L1C, and Al137845 were common,
and Ac004200 and Al356438 were rare) (34). Using the gene
frequencies of the four common hot L1s in our 80 individuals, we
estimate that L1A, L1B, and L1C account for 23 of these L1s in
the population. Boissinot et al. (55) isolated Ta-1 elements from
four other humans of diverse origin and, by extrapolation, found
that Ta-1 elements in HGWD account for 12 of common Ta-1
elements in the population. Although these estimates are fraught
with potential error, the data suggest that L1A, L1B, and L1C
account for at least 13 of the common hot L1 activity (23  12).
After other hot L1s are studied in these and other individuals, we
predict that the proportion of individuals at the extremes of the
distribution of retrotransposition capability will decrease some-
what, but the difference in retrotransposition potential of individ-
uals at those extremes will increase. Thus, we conclude that
individual variation in retrotransposition capability is an important
contributor to human genetic diversity.
Materials and Methods
L1 Elements Analyzed. Sequence polymorphisms in three FL L1
elements were analyzed. Al512428, Ac02980, and Ac021017, which
we call L1A, L1B, and L1C, respectively, belong to the replicatively
dominant Ta-1 subfamily (29) that is subdivided into two groups
depending on the presence (Ta-1d, L1B, and L1C) or absence
(Ta-1nd and L1A) of nucleotide G74. For details of the genomic
locations and insertion signatures of the elements, see Table 6,
which is published as supporting information on the PNAS web site.
DNA Samples. One hundred sixty-one to 206 gender-typed haploid
genomes from human variation panels of subSaharan African,
African American, Asian, European, South American, Indo
Pakistani, and Pacific origins were obtained from Coriell Cell
Repositories and the laboratory of M.A.B. Because of sample size
heterogeneity, some populations were pooled to increase statistical
power. For specific details see Supporting Methods in Supporting
Text.
PresenceAbsence Polymorphism, PCR, and Sequencing. Presence
absence polymorphism status was determined by using a three-
primer–two-PCR assay (30). Sequence polymorphisms of FL L1s
were obtained by direct sequencing of the PCR products of
Fig. 4. Model of the evolution of an L1 insertion in a population. Data
presented here and evidence that hot L1s account for most new insertions (34)
suggest that new insertions are derived from hot L1s. Data on alleles of L1A,
L1B, L1C, and LRE1 (36, 37) indicate that, after a hot L1 reaches an intermediate
gene frequency in the population, it has a significant proportion of cool
alleles. As an L1 approaches fixation, mutations produce cool alleles and dead
alleles. Shaded box, L1 insertion in chromosomes (lines); black dots, mutations.









































heterozygous and homozygous genomes. The final assignment of
nucleotide changes in homozygous genomes was made after se-
quencing of cloned products. Procedures to perform presence
absence polymorphism assays to obtain high-quality DNA and the
primers used are described in Supporting Methods in Supporting
Text; and see Table 7, which is published as supporting information
on the PNAS web site. To minimize the amplification of potential
PCR errors, we used Phusion Hi-fi DNA Polymerase (MJ Re-
search, Cambridge, MA), which has the lowest error rate of
currently available proofreading enzymes. For both sequencing and
cloning, we systematically pooled products of at least three inde-
pendent PCRs.
Sequence and Polymorphism Analyses. Sets of 11 overlapping se-
quences covering each FL L1 were imported into SEQUENCHER 4.5
and aligned to HGWD sequence. Nucleotides different from
HGWD sequence were verified manually in the chromatograms
and considered new alleles. In cases of unclear nucleotide readings,
DNA was repurified from new PCR products and resequenced.
Allele files were generated with MACVECTOR 8.02, and consensus
sequences were obtained with CLUSTALW. The evolutionary history
of mutations was reconstructed with Median Joining (MJ) net-
works (42). Neutrality departure tests (Tajima’s D, Fu and Li’s D*,
and Fu’s Fs) were performed with DNASP and ARLEQUIN software
suites.
Cloning of L1 Alleles, Transfection, Retrotransposition Assay, and
Definition of Activity Categories. FL L1s were isolated from het-
erozygous and homozygous genomes, cloned into a vector carrying
the EGFP retrotransposition cassette, sequenced to verify allelic
changes, and tested for activity in human 143B thymidine kinase
(TK) cells (45). Details of cloning, transfection, and activity
categories definition by using CART software can be found in
SupportingMethods in Supporting Text. Under our PCR conditions,
very few cloned elements had PCR errors (estimated error rate
1.9  105), and those clones were discarded. Thus, activity
differences observed for different clones of an L1 were relatively
minor and due to biological variation intrinsic to the assay. Activity
differences among L1s cloned here and in previous analyses (34, 56)
are discussed in Supporting Discussion in Supporting Text.
We thank D. Babushok for helpful suggestions and C. N. Talchai for
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